EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Operating income, 2025
- $1.3B
- YoY, 2025
- −8.3%
- 5-year CAGR
- +7.1%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $1.3B | −8.3% |
| 2024 | $1.4B | +5.3% |
| 2023 | $1.3B | −12.6% |
| 2022 | $1.5B | −11.4% |
| 2021 | $1.7B | +88.3% |
| 2020 | $898M | −21.7% |
| 2019 | $1.1B | +53.3% |
| 2018 | $748M | −31.3% |
| 2017 | $1.1B | +45.0% |
| 2016 | $751M | — |